HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysosomal protease cathepsin D; a new driver of apoptosis during acute kidney injury.

Abstract
Acute kidney injury (AKI) is an abrupt reduction in kidney function caused by different pathological processes. It is associated with a significant morbidity and mortality in the acute phase and an increased risk of developing End Stage Renal Disease. Despite the progress in the management of the disease, mortality rates in the last five decades remain unchanged at around 50%. Therefore there is an urgent need to find new therapeutic strategies to treat AKI. Lysosomal proteases, particularly Cathepsin D (CtsD), play multiple roles in apoptosis however, their role in AKI is still unknown. Here we describe a novel role for CtsD in AKI. CtsD expression was upregulated in damaged tubular cells in nephrotoxic and ischemia reperfusion (IRI) induced AKI. CtsD inhibition using Pepstatin A led to an improvement in kidney function, a reduction in apoptosis and a decrease in tubular cell damage in kidneys with nephrotoxic or IRI induced AKI. Pepstatin A treatment slowed interstitial fibrosis progression following IRI induced AKI. Renal transplant biopsies with acute tubular necrosis demonstrated high levels of CtsD in damaged tubular cells. These results support a role for CtsD in apoptosis during AKI opening new avenues for the treatment of AKI by targeting lysosomal proteases.
AuthorsPasquale Cocchiaro, Christopher Fox, Nicholas W Tregidgo, Rachel Howarth, Katrina M Wood, Gerhard R Situmorang, Luigi M Pavone, Neil S Sheerin, Anna Moles
JournalScientific reports (Sci Rep) Vol. 6 Pg. 27112 (06 07 2016) ISSN: 2045-2322 [Electronic] England
PMID27271556 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Pepstatins
  • Folic Acid
  • CTSD protein, human
  • Cathepsin D
  • pepstatin
Topics
  • Acute Kidney Injury (drug therapy, etiology, metabolism, physiopathology)
  • Animals
  • Apoptosis
  • Cathepsin D (metabolism)
  • Cell Line
  • Disease Models, Animal
  • Folic Acid (adverse effects)
  • Humans
  • Kidney Function Tests
  • Kidney Tubules (cytology, drug effects, enzymology)
  • Male
  • Mice
  • Nephrosis (chemically induced, complications, drug therapy, enzymology)
  • Pepstatins (administration & dosage, pharmacology)
  • Reperfusion Injury (complications, drug therapy)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: